Home > Financial Ratios > IPCA LABORATORIES

IPCA LABORATORIES
Core EBITDA Growth

    Back to All Ratios
IPCA LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

IPCA LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 25.7837.28-23.51-14.3564.84

What is the latest Core EBITDA Growth ratio of IPCA LABORATORIES ?

The latest Core EBITDA Growth ratio of IPCA LABORATORIES is 25.78 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202525.78
Mar202437.28
Mar2023-23.51
Mar2022-14.35
Mar202164.84

How is Core EBITDA Growth of IPCA LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 25.78
-30.85
Mar2024 37.28
Positive
Mar2023 -23.51
Negative
Mar2022 -14.35
Negative
Mar2021 64.84 -

Other Financial Ratios of IPCA LABORATORIES


Compare Core EBITDA Growth ratio of peers of IPCA LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
IPCA LABORATORIES ₹36,941.3 Cr 0.2% -3.3% -3.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics


IPCA LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
IPCA LABORATORIES

0.2%

-3.3%

-3.1%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses